Johnson & Johnson, Takeda Recall Velcade Drug Batches
This article is for subscribers only.
Johnson & Johnson and Takeda Pharmaceuticals Co. are recalling batches of their Velcade blood-cancer medicine in the U.K., U.S. and Japan after reports of impurities.
The recall is a “precaution” after five reports of visual particulates were received following product reconstitution in samples from two batches, according to a statement yesterday on the website of the U.K.’s Medicines and Healthcare Products Regulatory Agency. The six affected batches of the medicine, sold in powder form in 3.5-milligram strength, were first distributed from Jan. 5 to June 16, the statement said.